We are live on ! Find out more
SCM

Stonepine Capital Management Portfolio holdings

AUM $250M
1-Year Est. Return 77.6%
This Fund
S&P 500
This Quarter Est. Return
-2.81%
1 Year Est. Return
+77.6%
3 Year Est. Return
+198.76%
5 Year Est. Return
+226.15%
10 Year Est. Return
+1,976.54%
AUM
$170M
AUM Growth
-$15.5M
Cap. Flow
-$8.11M
Cap. Flow %
-4.78%
Top 10 Hldgs %
77.17%
Holding
32
New
5
Increased
6
Reduced
10
Closed
10

Top Buys

1
PCRX icon
Pacira BioSciences
PCRX
+$15.1M
2
APEN
Apollo Endosurgery, Inc.
APEN
+$12.5M
3
BSTC
BioSpecifics Technologies Corp.
BSTC
+$7.25M
4
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
+$4.32M
5
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$2.64M

Top Sells

1
VCEL icon
Vericel Corp
VCEL
+$7.69M
2
VNDA icon
Vanda Pharmaceuticals
VNDA
+$6.44M
3
ALR
Alere Inc
ALR
+$5.02M
4
DRRX
DURECT Corp
DRRX
+$4.96M
5
CUTR
Cutera, Inc.
CUTR
+$4.53M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRRX
26
DELISTED
DURECT Corp
DRRX
– –
-317,599
Closed -$4.96M
CUTR
27
DELISTED
Cutera, Inc.
CUTR
– –
-175,000
Closed -$4.53M
NEOS
28
DELISTED
Neos Therapeutics, Inc
NEOS
– –
-565,100
Closed -$4.13M
FOMX
29
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-2,878
Closed -$13K
CORI
30
DELISTED
Corium International, Inc.
CORI
– –
-413,568
Closed -$3.08M
SCLN
31
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
– –
-216,307
Closed -$2.38M
ALR
32
DELISTED
Alere Inc
ALR
– –
-100,000
Closed -$5.02M
1
2

Similar funds

BIA
Bigelow Investment Advisors Portland, Maine $250M AUM 19.33% 1-Year Est. Return
TGP
TMT General Partner Hong Kong $250M AUM 6.05% 1-Year Est. Return
ER
EVR Research Richmond, Virginia $250M AUM 41.5% 1-Year Est. Return
FDDB
Fidelity D&D Bancorp Dunmore, Pennsylvania $249M AUM 18.9% 1-Year Est. Return
VM
VPR Management Houston, Texas $250M AUM 34.13% 1-Year Est. Return
PF
Parker Financial Silverdale, Washington $250M AUM 14.69% 1-Year Est. Return
SCM
Step Capital Management Singapore $249M AUM
CWM
Chicago Wealth Management Chicago, Illinois $251M AUM 45.31% 1-Year Est. Return

Stonepine Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Stonepine Capital Management held 32 positions worth $170M, down 8.4% from $185M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Stonepine Capital Management withdrew a net $8.11M in Q3 2017, closing 10 positions and reducing 10 holdings. Its most notable exit was Alere Inc, an estimated $5.02M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Stonepine Capital Management opened a new position in Pacira BioSciences worth $14.1M.

  • Stonepine Capital Management's largest Q3 2017 buy was Pacira BioSciences: 375,200 shares worth $14.1M.
  • Stonepine Capital Management added most to BioSpecifics Technologies Corp. in Q3 2017, an estimated $7.25M increase.
  • Stonepine Capital Management's biggest Q3 2017 reduction was Vericel Corp, cutting an estimated $7.69M.
  • Stonepine Capital Management fully exited Alere Inc in Q3 2017, selling an estimated $5.02M.
  • Stonepine Capital Management's ten largest holdings make up 77% of its $170M portfolio in Q3 2017.
  • Stonepine Capital Management opened 5 new positions and closed 10 in Q3 2017.
  • Stonepine Capital Management's portfolio value fell 8.4% quarter-over-quarter to $170M.

Based on Stonepine Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.